Combined therapy of arterial hypertension;Kombinovaná terapie arteriálńi hypertenze

Vnitrni Lekarstvi

Volumn 59, Issue 5, 2013, Pages 366-369

  Rosolová, Hana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Compliance with treatment; Fixed combination; Telmisartan; Thiazide diuretics; Treatment of arterial hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PATIENT EDUCATION; REVIEW; RISK; THERAPY EFFECT;

ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION;

EID: 84878485222     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Bangalore S, Kamalakkannan G, Parkar S et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120: 713-719. (Pubitemid 47176510)
2. Vrijens B, Vincze G, Kristanto P et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-1117. (Pubitemid 351731741)
3. Filipovský J, Widimský jr. J, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58: 785-801.
4. Wald DS, Law M, Morris JK et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009; 122: 290-300.
5. Dahlhof B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an antihypertensive regiment of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the in the Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure LOwering Arm (ASCOT- BPLA): a multicenter rendomised controlled trial. Lancet 2005; 364: 1-12.
6. Bakris G, Molitch M, Hewkin A et al. Differences in glucose tolerance between fixed-dose anti hypertensive drug combinations in people with metabolic syndrome. Diabetes Care 2006; 29: 2592-2597. (Pubitemid 44912184)
7. Messerli FH, Makani H, Benjo A et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol 2011; 57: 590-600.
8. Dorsch M, Gillespie BW, Erickson SR et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011; 57: 689-694.
9. Pfeffer MA, Swedberg K, Granger CB et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759-766. (Pubitemid 37093915)
10. Benson SC, Pershadsingh HA, Ho Cl et al. Identification of telmisartan as a unique antagonist with selective PPAR gamma modulating activity. Hypertension 2004; 43: 993-1002. (Pubitemid 38579904)
11. Schumacher H, Mancia G The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies. Blood Press Suppl 2008; 1: 32-40.
12. Abe M, Okada K, Maruyama T et al. Blood pressure lowering and antiproteinuric effect of switching from high-dose ARBs to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease. Int J Clin Pharmacol Ther 2010; 48: 206-213.
13. Barnett AH, Bain SC, Bouter P et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004; 351: 1952-1961. (Pubitemid 39447136)
14. Neutel JM, Littlejohn TW, Chrysant SG et al. Telmisartan/ Hydrochlorothiatzide in comparison with losartan/Hydrochlorothiazide in managing patients with mild-to-moderate hypertension. Hyperstens Res 2005; 28: 555-563. (Pubitemid 41387285)
15. White WB, Lacourciere Y, Davidal G. Effect of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens 2004; 17: 347-353. (Pubitemid 38446850)
16. Marfatia R, White WB, Schumacher H. Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in patients with moderate-to-severe hypertension. Intern J Hypertens 2012; doi:101155/2012/ 976828.
17. Yusuf S, Teo K, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559. (Pubitemid 351522739)
18. Masayoshi Kojima, Masuo Ohashi, Yasuaki Dohi et al. Titration of telmisartan, but not addition of amlodipin, reduces urine albumin in diabetic patients treated with telmisartan-diuretic. J Hypertens 2013; 31: 186-191.